Skip to main content

Rigel Pharmaceuticals Relocates to South San Francisco

Published 12/12/2001

Rigel Pharmaceuticals has plans to relocate from 65,000 sf of lab space at the Britannia Pointe Grand Business Park to a new two-building lab facility at Slough Estate’s 22-acre Shearwater development in South San Francisco. The new buildings, which will total 140,000 sf, will begin construction this year. Rigel, whose focus is fluorescent gene marking, anticipates relocating to the new complex in 2002. Completion of the entire seven-building, 570,000-sf Shearwater development is anticipated by summer 2004.